Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their Caregivers

Recruiting in Palo Alto (17 mi)

Overseen byArya Amini

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: City of Hope Medical Center

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial studies comprehensive geriatric and quality of life assessments in older patients with head and neck or lung cancer that has or has not spread to other parts of the body who are undergoing standard surgery or chemoradiation, and their caregivers. Comprehensive geriatric assessment may improve the quality of life of patients with head and neck or lung cancer and their caregivers.

Eligibility Criteria

Inclusion Criteria

PATIENT: Diagnosed with non-metastatic or metastatic head and neck cancer or lung cancer

PATIENT: Scheduled to undergo either upfront surgery or definitive radiation treatment (including CRT)

PATIENT: Age >= 65 years

See 5 more

Treatment Details

Interventions

Comprehensive Geriatric Assessment (Behavioural Intervention)
Quality-of-Life Assessment (Behavioural Intervention)
Questionnaire Administration (Behavioural Intervention)

Participant Groups

2Treatment groups

Experimental Treatment

Group I: Group II (quality of life assessment)Experimental Treatment2 Interventions

Family caregivers complete quality of life assessment at baseline, and at 1, 3, and 6 months following patient radiation or CRT completion.

Group II: Group I (geriatric and quality of life assessments)Experimental Treatment3 Interventions

Patients complete comprehensive geriatric and quality of life assessments within 1-4 weeks of treatment (either upfront surgery which may be followed by radiation with or without chemotherapy or upfront radiation which may include CRT) initiation (baseline), and at 1, 3, and 6 months following CRT completion.